Although the development of irAEs correlates with improved efficacy of PD-1/PD-L1 inhibitors [82], ICI-related pneumonitis and myocarditis of any grade have been associated with decreased survival in NSCLC patients [83, 84]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.